Pharmaceutical Executive, Apr 1, 2010 - Pharmaceutical Executive

ADVERTISEMENT

Pharmaceutical Executive, Apr 1, 2010
Features
Woman of the Year: Deirdre Connelly
By Oriana Schwindt
As head of GSK's North American pharma, Deirdre Connelly has the daunting challenge of trying to turn around the sluggish US market. If she succeeds, Connelly may find herself auditioning as the first female Big Pharma CEO.
Managing the Three Drivers of Risk in Drug Development
By Adrian McKemey , Badhri Srinivasan , Peter Payne
Re-examining service provider roles can bring safety and speed on the road to registration.
Q&A: Geno Germano
By William Looney
Pfizer's Specialty Product Business Unit leader discusses his vision for the drug giant's specialty business; now the largest in the industry.
Brave Neuro World
By Walter Armstrong
Cognitive enhancement is a $20 billion market of aging Boomers, cramming students, global travelers, and battling soldiers. What's pharma going to do about it.
Columns
Out of the Quagmire
Industry needs an effective, unbiased method for funding medical education.
3D Competitive Analysis
By Stan Bernard, MD
Companies need to employ 3D analysis to assess markets, stakeholders, and competitors
Twice as Nice
Dutch pharma releases the same drug as a brand and a generic. Will this two-pronged attack work?
Back Page
How to Save Your Drug Company
Big thinker Bernard Munos delivers the goods.
From the Editor
A Challenging Harvest
By William Looney
Success in this harsh climate depends on seeing business through the eye of the customer
Washington Report
Science to the Rescue
By Jill Wechsler
FDA Commissioner Margaret Hamburg looks to bolster the agency's scientific expertise.

ADVERTISEMENT

Click here